Ryan Langston Analyst PerformanceDirector & Senior Analyst - Healthcare Equity Research at TD CowenRyan Langston is a stock analyst at TD Cowen in the medical sector, covering 18 publicly traded companies. Over the past year, Ryan Langston has issued 38 stock ratings, including buy and hold recommendations. While full access to Ryan Langston's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ryan Langston's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings40 Last 1 YearsBuy Recommendations52.50% 21 Buy RatingsCompanies Covered18 Unique Companies Ratings Distribution40RatingsDistribution of strong buy, buy, hold, and sell ratings by Ryan Langston.RatingPercentageCount Strong Buy0.0%0 ratings Buy52.5%21 ratings Hold47.5%19 ratings Sell0.0%0 ratingsOut of 40 total stock ratings issued by Ryan Langston at TD Cowen, the majority (52.5%) have been Buy recommendations, followed by 47.5% Hold.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNYSE66.7% of companies on NYSE12 companiesNASDAQ33.3% of companies on NASDAQ6 companiesRyan Langston, an analyst at TD Cowen, currently covers 18 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical18 companies100.0%Ryan Langston of TD Cowen specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMEDICAL SERVICES5 companies27.8%MED - OUTP/HM CRE4 companies22.2%MED - HMO4 companies22.2%MED - HOSPITALS4 companies22.2%MEDICAL INFO SYS1 company5.6% Ryan Langston's Ratings History at TD Cowen Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsEHCEncompass Health5/28/2026Initiated Coverage$104.40$125.00Buy$0.0000.00% ROIPIIIP3 Health Partners5/22/2026Reiterated Rating$13.81$14.00Hold$0.0000.00% ROIASTHAstrana Health5/12/2026Boost Price Target$37.97$45.00Buy$0.0000.00% ROIDVADaVita5/11/2026Boost Price Target$200.74$201.00Hold$0.0000.00% ROIAGLAgilon Health5/11/2026Reiterated Rating$52.50$55.00Hold$0.0000.00% ROIDVADaVita5/11/2026Boost Price Target$199.17$201.00Hold$0.0000.00% ROICNCCentene5/4/2026Reiterated Rating$53.42$47.00Hold$0.0000.00% ROIHUMHumana5/1/2026Boost Price Target$232.26$211.00Hold$0.0000.00% ROIUHSUniversal Health Services4/29/2026Lower Price Target$168.69$230.00Buy$0.0000.00% ROIACHCAcadia Healthcare4/28/2026Boost Price Target$28.15$30.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. HCAHCA Healthcare4/27/2026Lower Price Target$441.23$500.00Buy$0.0000.00% ROIUNHUnitedHealth Group4/23/2026Boost Price Target$353.50$337.00Hold$0.0000.00% ROIPIIIP3 Health Partners4/2/2026Lower Price Target$2.69$3.00Hold$0.0000.00% ROIHCAHCA Healthcare3/10/2026Boost Price Target$538.09$561.00Buy$0.0000.00% ROIEHABEnhabit3/6/2026Reiterated Rating$13.61$13.80Hold$0.0000.00% ROISGRYSurgery Partners3/5/2026Lower Price Target$13.88$20.00Buy$0.0000.00% ROIACHCAcadia Healthcare2/26/2026Boost Price Target$21.68$24.00Buy$0.0000.00% ROIHUMHumana2/13/2026Lower Price Target$181.25$173.00Hold$0.0000.00% ROITHCTenet Healthcare2/12/2026Reiterated Rating$234.00Buy$0.0000.00% ROICNCCentene2/11/2026Boost Price Target$39.83$38.00Hold$0.0000.00% ROIMOHMolina Healthcare2/9/2026Lower Price Target$125.58$144.00Hold$0.0000.00% ROIDVADaVita2/3/2026Reiterated Rating$135.38Hold$0.0000.00% ROIHCAHCA Healthcare1/28/2026Reiterated Rating$485.61Buy$0.0000.00% ROIALHCAlignment Healthcare1/16/2026Boost Price Target$22.50$25.00Buy$0.0000.00% ROIACHCAcadia Healthcare1/16/2026Lower Price Target$11.66$22.00Buy$0.0000.00% ROIEHABEnhabit1/13/2026Upgrade$10.18$12.00Buy$0.0000.00% ROITHCTenet Healthcare1/7/2026Lower Price Target$203.81$230.00Buy$0.0000.00% ROIUHSUniversal Health Services1/7/2026Lower Price Target$209.18$245.00Buy$0.0000.00% ROIELVElevance Health11/26/2025Boost Price Target$336.93$400.00Buy$0.0000.00% ROIASTHAstrana Health11/10/2025Lower Price Target$23.54$35.00Buy$0.0000.00% ROIADUSAddus HomeCare11/5/2025Boost Price Target$117.75$140.00Buy$0.0000.00% ROIDVADaVita11/3/2025Lower Price Target$117.17$133.00Hold$0.0000.00% ROICNCCentene10/31/2025Boost Price Target$34.72$34.00Hold$0.0000.00% ROIUNHUnitedHealth Group10/30/2025Boost Price Target$344.57$338.00Hold$0.0000.00% ROIHCAHCA Healthcare10/27/2025Boost Price Target$458.39$490.00Buy$0.0000.00% ROIELVElevance Health10/23/2025Boost Price Target$340.77$380.00Buy$0.0000.00% ROIADUSAddus HomeCare8/6/2025Boost Price Target$115.61$139.00Buy$0.0000.00% ROICNCCentene7/21/2025Reiterated Rating$27.95$33.00Hold$0.0000.00% ROIUNHUnitedHealth Group5/19/2025Reiterated Rating$312.34$308.00Hold$000.0000.00% ROIAGLAgilon Health4/15/2025Boost Price Target$135.63$150.00Hold$00.0000.00% ROIRead this warning immediately (Ad)Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.Read Porter Stansberry's full breakdown and protect your wealth now Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
